期刊文献+

脑胶质瘤中脆性组氨酸三联体和PTEN的表达 被引量:1

Expressions of FHIT and PTEN in Brain Gliomas
下载PDF
导出
摘要 目的检测抑癌基因脆性组氨酸三联体(FHIT)、PTEN在胶质瘤中的表达,并探讨其与肿瘤恶性程度的关系。方法采用免疫组织化学SP法,检测80例胶质瘤、5例正常脑组织中的FHIT、PTEN蛋白的表达。结果FHIT主要定位于肿瘤细胞的细胞质,PTEN主要定位于肿瘤细胞的细胞核,总阳性率分别为47.5%(38/80)、55.0%(44/80);FHIT和PTEN在正常脑组织中表达率均为80%(4/5),两者在正常脑组织和不同级别胶质瘤之间的表达均有差异(P<0.05),且随胶质瘤恶性程度的增加而减弱。结论FHIT和PTEN在胶质瘤细胞中表达减少或缺失,两者协同作用促进胶质瘤的发生发展。 Objective To examine the expressions of FHIT and PTEN in gliomas, and to investigate the relationship between their expressions and the degree of tumor malignancy. Methods SP Immunohistochemical staining was used to examine the expressions of FHIT, PTEN in 80 gliomas and in 5 normal brain tissues. Results FHIT was located in the plasma of glioma cells,PTEN was located in the cellular nuclei of glioma cells, total positive rates were 47. 5% (38/80) ,55.0% (44/80)respectively. Expression rates of FHIT and PTEN in normal brain tissues were 80% (4/5). There was a statistically significant difference in the expression of FHIT and PTEN between normal brain tissues and different grades of gliomas (P〈0. 05). Both of the expressions of FHIT and PTEN weakened with the rise in the degree of glioma malignancy. Conclusion Expressions of FHIT and PTEN in glioma cells are diminishing or absent, their cooperative operation promotes generation and advance of glioma.
出处 《肿瘤防治研究》 CAS CSCD 北大核心 2007年第6期423-424,463,I0004,共4页 Cancer Research on Prevention and Treatment
关键词 胶质瘤 脆性组氨酸三联体(FHIT) PTEN Glioma FHIT PTEN
  • 相关文献

参考文献6

  • 1Pekarsky Y,Palamarchuk A,Huevner K,et al.FHIT as tumor suppressor:mechanisms and therapeutic opportunities[J].Cancer Biology and Therapy,2002,1(3):232-236.
  • 2Matthews CP,Shera K,Kiviat N,et al.Expression of truncated FHIT transcripts in cervical cancers and in normal human cells[J].Oncogene,2001,20(34):4665-4680.
  • 3Geradts J,Fong KM,Zimmerman PV,et al.Loss of Fhit expression in non-small-cell lung cancer:correlation with molecular genetic abnormalities and clinicopathological features[J].Br J Cancer,2000,82(7):1191-1197.
  • 4Ishii H,Dumon KR,Vecchione A,et al.Potential cancer therapy with the fragile histidine triad gene:review of the preclinical studies[J].JAMA,2001,286(19):1441-1449.
  • 5Raftopoulou M,Etienne-Mannerville S,Self A,et al.Regulation of cell migration by the c2 domain of the tumor suppressor PTEN[J].Science,2004,303(5661):1179-1181.
  • 6Gomez-Manzano C,Fueyo J,Jiang H,et al,Mechanisms underlying PTEN regulation of vascular endothelial growth factor and angiogenesis[J].Ann Neurol,2003,53(1):109-117.

同被引文献11

  • 1董胜翔,黄钢.Prox-1:一种与实体肿瘤淋巴结转移相关的细胞内标志[J].肿瘤基础与临床,2007,20(2):183-184. 被引量:3
  • 2Tamador Elsir, MD,Anna Eriksson,PhD,Abiel Orrego. Expression of Prox-1 is a common feature of high-grademalignant astrocytic gliomas [J]. Neuropathol Exp Neurol,2010,69(2):129-138.
  • 3Misra K,Gui H,Matise MP. Proxl regulates a transitory state for interneuron neurogenesis in the spinal cord[J]. Dev Dyn 2008,237: 393-402.
  • 4Lindgren RM,Zhao J, Heller S,et al. Molecular cloning and characterization of two novel truncated isoforms of human Na^+/Ca^2+ exchanger3, expressed in fetal brain[J]. Gene, 2005,348 : 143-155.
  • 5Kononen J,Bubendorf L,Kallioniemi A,et al. Tissue microarraysf or high through putmoleeular profiling of tumor specimens[J]. Nat Mer. 1998,4 ( 7 ) : 844-847.
  • 6Mutti A. Molecular diagnosis of lung cancer:an overview of rece developments[J]. Acta Biomed,2008,79( 1 ) : 11,.
  • 7Molina R,Auge JM,Escudero JM,et al. Mucins CA125,CA19.9, CA15.3 and TAG272.3 as tumor markers in patients with lung cancer:comparison with CYFRA 2121,CEA,SCC and NSE [J]. Tumour Biol,2008,29(6):371.
  • 8傅仲学,肖世尧,王春毅,张彦斌.转录因子Prox-1对大肠癌中淋巴管生成的作用[J].中华消化外科杂志,2007,6(6):455-458. 被引量:4
  • 9鲍为群,蔡嘉琳,吴洁,鲍克容.儿童脑胶质瘤Ki-67抗原表达及其意义[J].临床儿科杂志,2009,27(6):569-572. 被引量:1
  • 10李兰双,胡丽娜.宫颈癌淋巴道转移模型的建立及Prox-1临床意义初探[J].第三军医大学学报,2009,31(16):1585-1588. 被引量:5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部